![]() |
Sard Verbinnen & Co. represents Cue Health as the San Diego health technology company and maker of home test kits for COVID-19 readies an initial public offering.
The company's goal is to enable people to manage their health through real-time, actionable and connected health data.
Cue envisions a suite of testing kits to provide consumers lab-quality results in 20 minutes without the need to visit a medical facility.
It is working on test kits for influenza, respiratory syncytial virus, fertility, pregnancy and inflammation. Cue plans to file for FDA approval for those kits during the second half of next year.
The company signed a $480M agreement with the Pentagon and Dept of Health and Human Services in Oct. 2020 for 6M of its test kits.
The National Basketball Assn. counted on the Cue COVID-19 test during its 2020 “bubble season.”
Cue posted $201M in first-half revenues and earned $32.8M.
It plans to list its stock on the NASDAQ.


Joele Frank handles HealthSpan Partners as it ups its $25 per share offer for Surgery Partners, which uses FTI Consulting for strategic communications counsel.
Wendy’s has turned to Collected Strategies as it rejects what it calls an inadequate, unsolicited and non-binding takeover bid from a group led by Nelson Peltz’s Trian Partners.
Collected Strategies and AdvisRy Partners will handle Kaz Resources when it goes public in a $2B deal during the first half of next year.
FGS Global handles Marvell Technology as the semiconductor giant agrees to acquire Lumentum, a Joele Frank client, in all all-stock transaction worth $115B.
Ross Lovern, who advised clients on such matters as internal and external crises, M&A, litigation, restructurings and shareholder activism as a partner at Kekst CNC, has joined Prosek Partners as a managing director on its special situations team in New York.



